• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[嗜铬细胞瘤患者术前及术后使用钙拮抗剂进行抗高血压治疗]

[Pre- and postoperative antihypertensive treatment with calcium antagonist in pheochromocytoma].

作者信息

Colson P, Ribstein J, Chaptal P A, Mimran A, Roquefeuil B

机构信息

Anesthésie-réanimation B, CHU, Montpellier.

出版信息

Arch Mal Coeur Vaiss. 1990 Jul;83(8):1123-5.

PMID:2124450
Abstract

Medical preparation for pheochromocytoma surgery requires adrenergic blockade and restoration of euvolemia. Usually, this preoperative preparation consisted essentially of sequential and progressive adrenergic antagonism, alpha then beta blockade. This therapy is not easy to introduce and exposes to blood pressure collapses after tumor removal. By contrast, calcium channel blocking drugs like dihydropyridines offer efficacy and safety. Moreover, new intravenous (IV) agents (nicardipine, diltiazem) provide useful therapeutic tools to control, rapidly and with a dose-dependent effect, any undesired hemodynamic event during surgery. As a demonstration of this new therapeutic strategy for management of pheochromocytoma resection, we report here the cases of two patients who were exclusively treated with dihydropyridines. A 61 year-old woman and a 41 year-old man were scheduled for pheochromocytoma resection (left and right adrenal tumors, respectively). Both patients received dihydropyridines for preoperative preparation (nicardipine and nifedipine, respectively, 60 mg/day). This treatment allowed a good control of arterial blood pressure (BP) (from 210/110 to 170/90 and 180/100 to 140/80 mmHg, respectively) and was maintained up to the morning of the operative day. After patient installation on the operating-table, IV nicardipine infusion was started (2 mg/hour). Anesthesia consisted of high doses of fentanyl, flunitrazepam and vecuronium. Hemodynamic measurements (radial artery and Swan ganz catheters) allowed adjustment of nicardipine infusion rate to maintain peripheral arterial resistances under 1,000 dynes.s.cm-5, and adequate volume loading. A hypertensive crisis (270/130 mmHg) occurred at the time of the intubation in the first case but responded to higher infusion rate of nicardipine (5 mg/10 min).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

嗜铬细胞瘤手术的医学准备需要进行肾上腺素能阻断并恢复血容量正常。通常,这种术前准备主要包括序贯性和渐进性的肾上腺素能拮抗,即先进行α阻断,然后进行β阻断。这种疗法引入并不容易,且在肿瘤切除后有血压骤降的风险。相比之下,像二氢吡啶类这样的钙通道阻滞剂具有疗效和安全性。此外,新型静脉用药(尼卡地平、地尔硫䓬)为控制手术期间任何不良血流动力学事件提供了有用的治疗工具,能快速且呈剂量依赖性地发挥作用。作为这种嗜铬细胞瘤切除术新治疗策略的例证,我们在此报告两名仅接受二氢吡啶类药物治疗的患者病例。一名61岁女性和一名41岁男性计划接受嗜铬细胞瘤切除术(分别为左侧和右侧肾上腺肿瘤)。两名患者均接受二氢吡啶类药物进行术前准备(分别为尼卡地平和平硝苯地平,60毫克/天)。这种治疗使动脉血压得到良好控制(分别从210/110降至170/90以及从180/100降至140/80毫米汞柱),并维持到手术当天早晨。患者安置在手术台上后,开始静脉输注尼卡地平(2毫克/小时)。麻醉采用高剂量芬太尼、氟硝西泮和维库溴铵。血流动力学测量(桡动脉和Swan - ganz导管)可调整尼卡地平输注速率,以维持外周动脉阻力低于1000达因·秒·厘米⁻⁵,并进行适当的容量负荷补充。第一例患者在插管时发生高血压危象(270/130毫米汞柱),但通过提高尼卡地平输注速率(5毫克/10分钟)得到缓解。(摘要截选至250字)

相似文献

1
[Pre- and postoperative antihypertensive treatment with calcium antagonist in pheochromocytoma].[嗜铬细胞瘤患者术前及术后使用钙拮抗剂进行抗高血压治疗]
Arch Mal Coeur Vaiss. 1990 Jul;83(8):1123-5.
2
[Exclusive use of calcium channel blockers and cardioselective beta-blockers in the pre- and per-operative management of pheochromocytomas. 70 cases].[钙通道阻滞剂和心脏选择性β受体阻滞剂在嗜铬细胞瘤术前及术中管理中的单独应用。70例病例]
Ann Chir. 1998;52(4):341-5.
3
[Anesthetic management of undiagnosed pheochromocytoma: a case report].[未确诊嗜铬细胞瘤的麻醉管理:一例报告]
Masui. 2008 Oct;57(10):1241-4.
4
Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas.口服尼卡地平与硫酸镁在嗜铬细胞瘤准备及切除术期间的应用。
Surgery. 2012 Dec;152(6):1027-36. doi: 10.1016/j.surg.2012.08.023.
5
[Use of magnesium sulfate during resection of pheochromocytoma].[嗜铬细胞瘤切除术中硫酸镁的应用]
Masui. 2002 May;51(5):516-7.
6
Preoperative management of pheochromocytoma with the calcium-antagonist nifedipine.
Clin Ther. 1985;7(3):372-9.
7
Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients.钙通道阻滞剂在嗜铬细胞瘤术前及术中控制中的单独应用:连续10例患者的血流动力学及游离儿茶酚胺检测
Surgery. 1989 Dec;106(6):1149-54.
8
Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma.在嗜铬细胞瘤的治疗中,术前使用α受体阻滞剂和钙通道阻滞剂对术中血流动力学稳定性的影响相似。
Surgery. 2014 Dec;156(6):1410-7; discussion1417-8. doi: 10.1016/j.surg.2014.08.022. Epub 2014 Nov 11.
9
[Adenosine triphosphate in the peroperative management of hypertensive crises and heart rate disorders in the surgical treatment of pheochromocytoma].[三磷酸腺苷在嗜铬细胞瘤手术治疗中高血压危象及心率紊乱围手术期管理中的应用]
Rev Esp Anestesiol Reanim. 1994 Sep-Oct;41(5):262-7.
10
[Anesthesia with transesophageal echocardiography for removal of pheochromocytoma].经食管超声心动图引导下麻醉用于嗜铬细胞瘤切除术
Masui. 1995 Oct;44(10):1388-90.

引用本文的文献

1
Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.嗜铬细胞瘤患者的药物不良反应:发生率、预防及管理
Drug Saf. 2007;30(11):1031-62. doi: 10.2165/00002018-200730110-00004.
2
Calcium channel blockade and uncontrolled blood pressure during phaeochromocytoma surgery.嗜铬细胞瘤手术期间的钙通道阻滞与血压失控
Can J Anaesth. 1995 Mar;42(3):228-30. doi: 10.1007/BF03010683.